SDIC Venture Capital

Beijing Surrey is a technology company founded by an industry elite active in China's medical equipment. Relying on the core technology of the new generation of flexible continuum robotic arm, running through the implementation paradigm of many types of clinical minimally invasive surgery, and harnessing the powerful system design and integration capabilities, Beijing Shurui is committed to becoming the first independent independent research and development, production and sales in China.

Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.

Grace Laser focuses on its mission to develop the national laser industry and its vision of building a brand of a domestic laser. The company was founded in 2014 and is headquartered in Beijing China.

TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.

RemeGen, Ltd. is a biopharmaceutical company based in Yantai, Shandong Province, China, specializing in the research, development, manufacture, and commercialization of novel biologics, particularly monoclonal antibodies and antibody-drug conjugates. The company focuses on addressing unmet medical needs for patients with life-threatening conditions, offering products such as Telitacicept for systemic lupus erythematosus and Disitamab Vedotin for various cancers. RemeGen's innovative therapies target major diseases, including autoimmune disorders, oncology, and ophthalmology. With additional laboratories and offices in Beijing and California, RemeGen primarily operates in China while also maintaining a presence in the United States, where it derives a significant portion of its revenue.

Beijing Biostar Technologies, Ltd. was incorporated in Haidian Park, Zhongguancun Science and Technology Park, Beijing, in July 2002. The national high-tech led by the team of Chinese scientists in the United States led by Dr. Tang Li and Dr. Qiu Rongguo. The company, focusing on biomedical development, technology and transfer of anti-tumor small molecule chemical drugs, and technical service consulting, pioneered the creation of new anti-cancer drugs for epothilone in China, and its technology is at the international advanced level.

Eucure Biopharma is a biotechnology company based in Beijing, China, specializing in the discovery and development of innovative immuno-oncology targeted antibodies. The company's primary focus is on immune checkpoints, with several products having advanced to the Chemistry, Manufacturing, and Controls (CMC) stage and clinical trials initiated in 2019. Eucure Biopharma aims to create antibody treatments that enhance the survival rates of patients with tumors, offering healthcare professionals more effective options for cancer treatment through the development of checkpoint and cancer growth inhibitors.

Zshield is the first high-tech company in China to focus on cyberspace data security and big data business risk management based on big data technologies such as “viewing”, “inspecting” and “walking”.The development of new technologies such as big data, cloud computing, software-defined networking (SDN), Bring Your Own Device (BYOD), and mobile applications has brought a new computing model and introduced new information security vulnerabilities. Traditional technologies such as firewalls, anti-virus, and intrusion detection have been unable to cope with these new and large-scale information security challenges due to architectural and design constraints. Based on new computing models and new technologies, Zhixiang Technology develops leading-edge integrated information security solutions to help customers meet new challenges in the cloud computing and big data era.

Beijing SkyGuard Network Security Technologies LLC, founded in 2015 and based in Beijing, China, specializes in network information security technology services. The company focuses on developing data security solutions that prioritize the protection of individuals and their data. In addition to its technology offerings, SkyGuard provides comprehensive consulting services, along with pre-sales and after-sales technical support, aimed at assisting enterprise users in enhancing their data security measures.

Eucure Biopharma is a biotechnology company based in Beijing, China, specializing in the discovery and development of innovative immuno-oncology targeted antibodies. The company's primary focus is on immune checkpoints, with several products having advanced to the Chemistry, Manufacturing, and Controls (CMC) stage and clinical trials initiated in 2019. Eucure Biopharma aims to create antibody treatments that enhance the survival rates of patients with tumors, offering healthcare professionals more effective options for cancer treatment through the development of checkpoint and cancer growth inhibitors.

Twenty First Century Aerospace Technology Co., Ltd specializes in commercial earth observation (EO) satellite operations and geospatial information services. Based in Beijing, the company manages a constellation of small satellites, including those capable of capturing 1-meter optical imagery. It provides a comprehensive range of services encompassing satellite procurement, operational management, data acquisition, image processing, and geo-information services. The company’s offerings include high-quality imaging data, value-added images, and spatial remote sensing services, as well as software solutions for image data processing and smart satellite management. Its geo-information services cater to various applications, including land cover analysis, change detection, and 3D simulation, supporting government and commercial sectors in areas such as city management, resource monitoring, and disaster response. Founded in 2001, Twenty First Century Aerospace Technology leverages advanced technology and algorithms for large-scale data processing to serve both domestic and international clients.